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ABSTRACT
OBJECTIVE: To identify the clinical pathways of women with breast cancer treated in 
public hospitals, and to analyze the factors that influence the time interval between the first 
appointment and the start of therapy. 
METHODS: A cross-sectional study was conducted with 600 women with breast cancer treated 
in nine public hospitals in the Brazilian Federal District. Patients were interviewed between 
September 2012 and September 2014. Simple and multiple logistic regression models were 
adjusted to evaluate the variables associated with the time interval studied. The most frequent 
pathway was the one that started in primary care with following care in the therapy service 
(28.9%). In the multiple adjustment, factors associated to a longer time interval between the 
first appointment and therapy were: lower family income (OR = 1.89; 95%CI 1.32–2.68), the first 
appointment in public services (OR = 1.78; 95%CI 1.20–2.64), care in more than two health services 
in the clinical pathway (OR = 1.71; 95%CI 1.19–2.44); and obtaining the anatomopathological 
analysis of the biopsy in public services instead of private health services (OR = 1.87; 95%CI 
1.29–2.71). Independently, the implementation of specialist appointment scheduling, with care 
regulation, was associated with a shorter time interval between first appointment and therapy 
(OR = 0.33; 95%CI 0.16–0.65). 
CONCLUSIONS: We observed that multiple pathways were covered by women with breast 
cancer treated in public services of the Federal District. Socioeconomic iniquities and several 
aspectos of the pathways covered were associated with a longer time interval between the first 
appointment and the start of breast cancer therapy.
DESCRIPTORS: Breast Neoplasms, therapy. Time-to-Treatment. Health Care Quality, Access, 
and Evaluation. Health Status Disparities. Health Services Accessibility.
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INTRODUCTION
Breast cancer is the most common neoplasm in women in Brazil and in the Federal 
District (DF – Distrito Federal), when not considering non-melanoma skin cancer. 
In 2018, approximately 60 thousand new breast cancer cases were estimated in 
Brazil, with more than a thousand in DF1. Despite the trend towards stabilization in 
breast cancer mortality rates in Brazil, these rates are growing in states with lower 
socioeconomic status2. This suggests socioeconomic inequities in the access to and 
use of health services, with delay in diagnosis and/or in the definition and start of the 
appropriate therapeutic option2,3.
The existence of properly prepared health services is critical to ensure the access to 
treatment of confirmed cases, via the early diagnosis and start of therapy in appropriate 
time4. However, the access to tests and to referral services for definitive diagnosis (secondary 
care) and for therapy (tertiary care) persist as critical parts. This demonstrates the difficulty 
of coordinating the different levels of care5 in a country where mechanisms to organize the 
flow of care are still lacking6 and the access to specialists is unavailable/limited7. These 
frailties may have contributed to most of the delay for diagnosis confirmation8 and early 
treatment9 of breast cancer being attributed to the health service, since this delay occurred 
after the women had their first appointment due to the identification of signs and symptoms 
suggestive of cancer or changes in tests8,9. 
Studies on the time interval between the first appointment and the start of therapy present 
different results when conducted in developed or developing countries10, considering that 
each study has its own contexts and peculiarities to analyze the determining factors11. 
Furthermore, it is a consensus that this interval must be as small as possible, since an 
interval of more than three months between the patient’s detection of the symptom and 
the start of therapy was associated with worse survival rates12, and that a late diagnosis 
leads to more aggressive treatments10.
Seeking to expand the access to public services and procedures within the Unified 
Health System (SUS)13 in an orderly, timely, equitable and rational manner, health care 
networks were organized and resulted in the structuring of regulatory centers; however, 
their functioning is still incipient13,14. Moreover, considering that access to health is based 
on availability, acceptability, capability of payment and information15, it is fundamental 
to consider that several contexts have influence on individuals’ personal behavior when 
choosing health services16. The interaction of different actors, among them patients, 
health professionals, administrators and health systems, determines the pathway and 
the wait for therapy17.
Thus, given the importance of improving the expedite of health care at different levels, the 
objective of this study was to identify the clinical pathways of women with breast cancer 
treated in public hospitals of DF and to investigate its association with the time interval 
between the first appointment and the start of therapy.
METHODS
This research is part of a study titled “Fatores associados ao tempo de acesso para o tratamento 
do câncer de mama no Distrito Federal, Brasil”, approved by the Research Ethics Committee 
of Fundação de Ensino e Pesquisa em Ciências da Saúde da Secretaria de Estado da Saúde 
do Distrito Federal (SES-DF) (Opinion 99.313).
A cross-sectional study was conducted with women with pathological diagnosis of breast 
cancer hospitalized for clinical or surgical therapy of this disease, who underwent the first 
therapy in one of nine public hospitals in the DF and who signed the informed consent form. 
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Prevalent cases of breast cancer and cases that presented metastatic disease prior to the 
start of therapy were not included in the study.
To calculate the sample size, the number of new cases of breast cancer estimated in the DF 
for the data collection period (1,800 new cases)18, the proportion of new cases treated by 
private health services (40%)19 and the prevalence of delay in starting breast cancer therapy 
after the first visit, considered as > 3 months time interval (77.6%)9, were used as the basis. 
Thus, it was estimated that 600 cases would be required.
Data collection from consecutive cases was performed between September 2012 and 
September 2014, using interviews guided by a structured questionnaire and the analysis 
of the patient’s medical record to obtain clinical data.
Women were questioned about the health services in which they were attended to, from 
the first appointment until the start of breast cancer therapy, in addition to the dates 
of these visits. Appointment cards, charts and test results were used to help patients 
remember the dates of their appointments. The place of the first visit was considered 
the one where the patient was initially examined to evaluate the clinical complaint 
in her breast, or the unit that requested or performed the tests whose results were 
considered suspect.
Appointments were considered specialized when the professional was a breast cancer 
specialist or surgical or clinical oncologist. Non-specialist appointments were those 
performed by primary care doctors or other specialties found in public outpatient services 
or in private health services.
Therapy service was the place that performed the surgery or that referred the patient 
to start chemotherapy. Intermediate services were those where the woman went to 
an appointment and was then referred to a specialist in the interval between the 
first non-specialist appointment and the therapy service. The date and place of this 
appointment were also collected.
Follow-up appointments, appointments with other doctors for preoperative evaluation and 
appointments that served only for a second opinion were not considered, as well as the dates 
of the review of the results of anatomopathological examinations.
The types of health services in which the women were attended to were classified as private 
services or as SUS public services, with the following subclassification: primary health 
care service (basic health unit or Estratégia Saúde da Família [Family Health Strategy]), 
emergency care service (emergency room), secondary or tertiary care service of other 
specialties (outpatient clinic without breast cancer specialist, surgical or clinical oncologist) 
or diagnosis and/or therapy service (outpatient clinic with breast cancer specialist, surgical 
and/or clinical oncologist).
The date of the surgery or the first chemotherapy session – in the cases that required 
neoadjuvant therapy – were registered as the date of the start of therapy.
In July 2013, the SES-DF implemented the clinical protocol for appointment scheduling 
with breast cancer specialists via a care regulation system, which prioritized specialized 
care for women with imaging tests suspected of malignancy. Previously, women were 
referred by verbal or written guidance, without the need for diagnostic tests and risk 
classification, leading to the same type of referral for women with benign or malignant 
diseases. The effect of this measure on the time interval between the first appointment 
and the treatment was evaluated by restricting the analysis to women from the DF and 
whose pathway started in primary care and with subsequent procedures being held in 
public diagnostic or therapy services. Considering this restriction, the sample for analysis 
of this independent variable totaled 220 women. Other variables analyzed were the 
following socioeconomic characteristics: age, self-reported skin color, place of residence 
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(DF or outside the DF), educational level and family income per month expressed in US 
dollars (1 USD = 2.7 BRL on December 31, 2014).
Data analysis encompassed percentage distribution of categorical variables and 
measures of central tendency and dispersion of the continuous variables. A simple 
Figure. Flowchart of the clinical pathway of 600 women with breast cancer until the start of 
therapy in nine public hospitals of the Federal District, Brazil, between September 2012 and 
 September 2014.
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logistic regression model was used to evaluate the association of predictor variables 
with a longer time interval between the first appointment and therapy. The response 
variable was dichotomized according to the median found, due to the low frequency 
of women with a time interval under three months. Following, a multiple logistic 
regression model was adjusted by the stepwise forward method. Variables that presented 
p ≤ 0.25 values in the simple model were tested in the multiple model20. Variables were 
kept in the model when p < 0.05. The software IBM SPSS Statistics v.20.0 was used for 
statistical analysis.
RESULTS
Among the 600 participants, the mean age at diagnosis was 53.3 years and most were 
between 50 and 69 years old (47%), self-reported as being brown (46.4%), lived in the Federal 
District (65.8%), reported 7.9 (±4.6) years of study on average and had mean monthly family 
income of USD 770 (±921.93), and USD 502.22 as the median. 
We identified a higher prevalence of the pathway with up to two health services, 
either the location of the first service followed by the first therapy service or the 
coincidence between the first service and the therapy service (56.2%) (Figure). In 17.1% of 
the cases, after attending the first health service, there were intermediary appointments 
in at least one specialized public service for diagnostic investigation before the 
therapy service.
Primary care was the place where the first appointment was performed more frequently, with 
private health services in second place (Table 1). Lower percentage of women performed their 
first appointment directly in specialized secondary or tertiary care service, in secondary 
or tertiary care service of other specialties or in emergency service (Figure).
The first appointment of 13.8% of the women was conducted with specialists. Out 
of these, 53.7% occurred in public services. Private health services were used to 
perform at least one test by most patients (97.3%) and were responsible for 43.3% of 
the anatomopathological biopsy results (Table 1). Considering patients who performed 
their first appointment in public services, 20.5% obtained the anatomopathological 
biopsy analysis in private services.
Many participants reported having used informal contacts from their own or from the 
health professionals who attended to them to achieve a more agile service in the health 
services (Table 1). 
The time interval between the f irst appointment and the start of the therapy 
presented 211.8 days mean (175.8 standard deviation) and 160 days median (162.5 
interquartile range).
Simple logistic regression is shown in Table 2. Variables that were significantly associated 
with a longer time interval were brown or black skin color, lower family income, lower 
educational level, first appointment in public services, more than two health services 
traversed in the clinical pathway, not using informal relationships to expedite care and 
having the anatomopathological biopsy analysis done in public services. There was no 
statistically significant association between the variables residence and cancer staging 
with the analyzed time interval (Table 2).
Regarding women from the Federal District whose pathway started in primary care, with 
subsequent treatment in specialized service or therapy service, the time interval was 
shorter for those referred after the implementation of the clinical protocol in the care 
regulatory system (Table 2). Due to presenting different amounts of the other independent 
variables, this variable was not inserted in the multiple model adjustments.
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In the adjustment of the multiple logistic regression model, a longer time interval between 
the first appointment and the start of therapy were found to be associated with women 
with lower family income, first appointment in public services, treatment in more than two 
health services in the pathway and the anatomopathological biopsy analysis results made 
in public services (Table 3).
Table 1. Time interval between the first appointment and the start of breast cancer therapy for 600 
women treated in nine public hospitals of the Federal District, Brazil, between September 2012 and 
September 2014, according to socioeconomic and pathway characteristics. 
Variable n %
Time interval between the 
first appointment  
and therapy
Median Q1–Q3
Place of residence
Federal District 395 65.8 153.0 105.0–249.0
Outside of the Federal District 205 34.2 180.0 102.0–304.0
Self-reported skin color
White 226 37.6 150.0 91.5–255.0
Brown or black 374 62.4 170.0 108.0–284.0
Family income (US$ per month)
> 502.20 272 46.7 135.0 91.0–217.0
≤ 502.20 311 53.3 188.0 120.0–303.5
Educational level (years)
> 8 283 52.9 145.0 88.0–246.5
≤ 8 317 47.1 172.0 117.0–284.0
First appointment location
Primary care 304 50.6 191.0 123.0–313.0
Private health services 199 33.1 133.0 86.0–202.5
Secondary or tertiary care of another specialty 28 4.7 202.5 107.0–259.0
Emergency 25 4.2 133.0 101.5–264.5
Diagnosis and/or therapy services 44 7.4 153.0 86.3–269.8
Number of health services covered
≤ 2 337 56.2 149.0 97.0–235.8
> 2 263 43.8 176.0 118.0–320.0
Use of informal relationships to expedite some service
Yes 234 39.0 145.0 90.0–228.0
No 366 61.0 177.5 117.5–285.5
Cancer staging
< IIB 255 42.5 161.0 106.0–280.5
≥ IIB 345 57.5 158.0 102.0–252.0
Anatomopathological biopsy analysis in private services
Yes 260 43.3 135.0 82.0–219.0
No 340 56.7 187.0 124.8–303.3
Regulation of appointments with specialistsb
Before implantation 176 80.0 196.0 129.0–321.0
After the implantation 44 20.0 137.0 103.3–191.8
a Differences that correspond to information loss.
b n = 220, referring to women from the Federal District whose pathway began in primary care services with 
subsequent care in specialized or therapy services.
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Table 3. Adjustment of the multiple logistic regression model between the response variable time interval 
between first appointment and therapy (≤ or > 160 days) and associated factors.
Variable Categories
Adjusted 
OR
95%CI p
Family income (US$ per month) > 502.20 1.00 - -
≤ 502.20 1.89 1.32–2.68 < 0.001
First appointment location Private services 1.00 - -
Public services 1.78 1.20–2.64 0.004
Number of health services covered ≤ 2 1.00 - -
> 2 1.71 1.19–2.44 0.003
Anatomopathological biopsy analysis in private services Yes 1.00 - -
No 1.87 1.29–2.71 0.001
Table 2. Time interval between the first appointment and the start of breast cancer therapy (≤ or > 160 days) 
for 600 women treated in nine public hospitals of the Federal District, Brazil, between September 2012 
and September 2014, with simple logistic regression using socioeconomic and pathway characteristics.
Variable
Time interval between the 
first appointment and therapy OR 95%CI
≤ 160 days > 160 days
Place of residence
Federal District 209 (34.8%) 186 (31.0%) 1.00 -
Outside of the Federal District 94 (15.7%) 111 (18.5%) 1.32 0.94–1.85
Self-reported skin colorb
White 128 (21.3%) 98 (16.3%) 1.00 -
Brown or black 176 (29.4%) 198 (32.9%) 1.47 1.05–2.05
Family income (US$ per month)b
> 502.20 164 (28.1%) 108 (18.5%) 1.00 -
≤ 502.20 127 (21.8%) 184 (31.6%) 2.20 1.58–3.07
Educational level (years)b
> 8 160 (26.5%) 123 (20.5%) 1.00 -
≤ 8 143 (23.9%) 174 (29.0%) 1.57 1.14–2.17
First appointment locationb
Private services 127 (21.2%) 72 (11.9%) 1.00 -
 Public services 175 (29.1%) 226 (37.8%) 2.31 1.62–3.28
Number of health services coveredb
≤ 2 181 (29.9%) 156 (25.9%) 1.00 -
> 2 121 (20.3%) 142 (23.9%) 1.36 0.98–1.88
Use of informal relationships to expedite some serviceb
Yes 134 (22.2%) 100 (16.8%) 1.00 -
No 166 (27.4%) 200 (33.7%) 1.63 1.17–2.28
Cancer staging
< IIB 128 (21.3%) 127 (21.2%)
≥ IIB 175 (29.2%) 170 (28.3%) 0.98 0.71–1.35
Anatomopathological biopsy analysis in private 
servicesb
Yes 161 (26.8%) 99 (16.5%) 1.00 -
No 142 (23.7%) 198 (33.0%) 2.27 1.63–3.16
Regulation of appointments with specialistsc
Before the regulation 68 (30.9%) 108 (49.1%) 1.00 -
After the regulation 29 (13.2%) 15 (6.8%) 0.33 0.16–0.65
a Differences that correspond to information loss.
b Variables that produced p ≤ 0.25 values.
c n = 220, referring to women from the Federal District whose pathway began in primary care services with 
subsequent care in specialized or therapy services. Due to presenting different amounts when considering other 
independent variables, this variable was excluded from the adjustment of the multiple model. 
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DISCUSSION
We observed that women with breast cancer treated in public hospitals in the Federal 
District followed multiple clinical pathways, the most frequent being the one that started 
in primary care with subsequent care in the service that performed the therapy. Women 
with greater social vulnerability took more time to follow these pathways.
Regarding the pathways, our results show the relevance of primary care as a gateway for 
the population to enter the health system, being the most common means of access to 
specialized care21. Other types of public health services were used less frequently as gateways.
Private health services were the second most frequent place of the first appointment. Other 
studies that analyzed the pathway until cancer therapy also observed that many patients 
sought care in private health services6,22.
These services were also used to perform tests, something that was also reported in other 
studies with patients treated in the SUS22–24. In this study, almost all women reported having 
performed at least one test in private health services, mainly with direct out-of-pocket 
costs. This may be due to previous experiences of difficulty in accessing the service, from 
the idea that there is delay in the scheduling of tests23 or the insufficient supply of specific 
procedures21 in the SUS. In Brazil, the main activities performed in private health services 
are appointments with specialists and diagnostic and therapeutic support services. These 
are bottlenecks of the SUS, in which patients face long waiting lists25, with greater difficulties 
in scheduling tests than scheduling specialized appointments21.
Researchers believe that the expansion of SUS primary care coverage lead to an increase in 
the demand for secondary and tertiary services, making the access to diagnostic services 
even more difficult24. The delay in obtaining the tests affects the access of new patients to 
specialized services, since it increases the number of return appointments until the case 
is resolved26.
The anatomopathological biopsy analysis was specifically evaluated to exemplify the effect 
of conducting the tests in private health services on the time to start breast cancer therapy. 
Approximately half the women performed this test in private services, a factor associated 
with greater speed for the start of therapy, suggesting that the public health system is still 
incapable of meeting the demand for specific tests for the early diagnosis of breast cancer. 
A Brazilian study found a shortage of biopsies when considering the diagnostic need 
estimated by the number of mammograms suspected of malignancy performed by the SUS27.
Given that the access to private services, both for specialized appointments and for tests, 
is related to higher family income, this variable also remained statistically significant in 
the multiple adjustment. This shows that higher family income helps patients to cope with 
critical issues to reach the start of breast cancer therapy in SUS; thus, corroborating the 
analysis of Santos, according to which the coverage of similar health services, and not only 
complementary, in the public and private scope, contributes to inequity in the provision, 
access and use of health services25.
Regarding the pathways, there was a greater frequency of patients from primary care services 
with subsequent treatment in specialized services and/or in the therapy service itself. 
This pathway is believed to be the most expected and adequate according to the hierarchy 
of regionalization of health services. Such pathway could be classified as the regime of 
governmental regulation since it was produced by the legal set that instituted SUS17.
Although it presents rational aspects, this regime is crossed by multiple interests and 
contradictions, being susceptible to arrangements and solutions made by patients, even 
when referred to predefined pathways17. This may have occurred with some women who had 
appointments in different services between the first appointment and the therapy service. 
Thus, when considering patients as protagonists facing SUS’s limitations, we cannot affirm 
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that the frailties of the services alone have motivated these women to seek different health 
services. However, as pointed out in other studies22,28,we cannot rule out that limitations 
in the effectiveness of the care provided and solution of some services may have favored 
variations in clinical pathways. Those who included more than two health services were 
associated with a longer time to start therapy. The referral from primary care to a specialized 
service capable of performing all diagnostic investigation would decrease the need of going 
through other services and possibly reduce the time to start therapy, as suggested by a 
Canadian study29.
Strengthening primary care in the ordering of access to other health care levels is critical 
to optimize the referral, as well as care regulation as an instrument to match supply to 
demand, prioritizing cases according to the classification of clinical criteria30. This study 
verified that the implementation of care regulation to schedule specialized appointments 
was associated with shorter time interval to start breast cancer therapy in the DF, a benefit 
previously pointed by another study31. Using this and other strategies that strengthen the 
interaction between administrators, health workers and patients can also contribute to 
a more agile access to therapy31 and, consequently, to the construction of an equitable 
health system30.
The use of informal relationships with health professionals to facilitate access was common 
among the participants of this study, which was also reported by other authors28,32. 
However, this variable did not remain in the multiple adjustment, indicating that using 
this mechanism did not interfere in the studied time interval. Nevertheless, we must 
emphasize that the range of care mediated by a health professional can be interpreted as 
a privilege, entailing the linkage of access to such professional, weakening the structure 
and organization of the system itself32.
Regarding cancer staging, we found no association with the evaluated time interval, possibly 
due to the relationship between these variables: clinical signs of breast cancer are more 
evident for doctors when the disease is at an advanced stage, which can lead to faster a 
diagnosis and treatment; on the other hand, slow-growing tumors would be more difficult 
to detect and diagnose33,34.
As a limitation of the study, we must emphasize that the quantitative approach restricted 
the possibility of analyzing the women’s interpretations on their pathway, as well as the 
repercussions of other factors – both in the pathway and in the studied time interval. 
Another possible limitation is the memory bias, for demanding the participants to recall 
past events. However, we believe that these limitations were minimized by using incident 
cases with few months elapsed between the experiences and the interview.
In conclusion, in this study, we observed multiple pathways used by women with breast 
cancer treated in the public services of the DF, with lower socioeconomic level and 
characteristics of the traversed pathways associated to a longer time interval between the 
first appointment and the start of breast cancer therapy. The difficulty to perform tests in 
the health care network for diagnosis and therapy was an important factor for the delay 
in the start of this therapy. Strengthening strategies such as care regulation was shown to 
be an effective possibility to improve access to medium and high complexity services and 
may contribute to reduce iniquities in the health care provided by SUS.
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